Status:
ACTIVE_NOT_RECRUITING
The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma
Lead Sponsor:
Ding Ma
Collaborating Sponsors:
Shandong University
Huazhong University of Science and Technology
Conditions:
Endometrial Neoplasms
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
This randomized trial is studying the efficacy and safety of the hysterectomy alone compared with hysterectomy and bilateral salpingo-oophorectomy (BSO) for patients with Stage IA endometrial carcinom...
Eligibility Criteria
Inclusion
- FIGO stage: ⅠA, endometrial carcinoma;
- Female, Chinese women;
- premenopausal women；
- ≤ 50 years old;
- Pathological diagnosis by curettage/hysteroscopy : G1
- No prior treatment;
- Provide written informed consent.
Exclusion
- The suspicious metastasis of ovarian;
- Family history of ovarian cancer;
- Suffering from other malignancies;
- Concurrently participating in other clinical trials;
- Unable or unwilling to sign informed consents;
- Unable or unwilling to abide by protocol.
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT01820884
Start Date
November 1 2012
End Date
December 1 2026
Last Update
April 2 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030
2
Qilu Hospital，Shandong University
Jinan, Shandong, China, 250012
3
Women's Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310006